HCA Healthcare(HCA) Stock Price Today | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

HCA Healthcare | 10-Q: Q1 2025 Earnings Report
SECMay 1 16:31 ET · Announcements
Is the Market Bullish or Bearish on HCA Healthcare?
BenzingaMay 1 09:00 ET
Should You Investigate HCA Healthcare, Inc. (NYSE:HCA) At US$345?
Yahoo FinanceMay 1 07:00 ET
Tenet Healthcare Q1 Results Exceed Expectations Due to Strong Volume, Cost Control, RBC Says
MT NewswiresApr 30 13:46 ET
HCA Healthcare Approves New Compensation Program
TipRanksApr 29 17:03 ET
A Quick Look at Today's Ratings for HCA Healthcare(HCA.US), With a Forecast Between $355 to $390
Moomoo NewsApr 29 09:00 ET · Ratings

Comments

CCS94

Apr 25 20:25

A great defensive company, HCA Healthcare. It reported better than expected Q1 2025 result

HCA Healthcare $HCA Healthcare (HCA.US)$ beat both Q1 2025 EPS and revenue."The solid fundamentals we saw in our business the past several quarters continued into the first quarter of 2025" - by Sam Hazen, Chief Executive Officer of HCA HealthcareHCA is up about 1.4% pre-market. And based on the technical analysis, if price could break above the 200MA (red line), I foresee it would continue to create a high...

Teddy123

Apr 11 15:43

Two Large Clinical Trials Find a Highly Effective Method to Select Appropriate Antibiotics for Patients Hospitalized With Abdominal or Skin and Soft Tissue Infection

$HCA Healthcare (HCA.US)$
Major Breakthrough: New System Cuts Wrong Antibiotic Use by 35% in Hospital Trials

HotHotHot

Feb 7 03:32

$HCA Healthcare (HCA.US)$ why suddenly go down

1

韭菜变主力

Jan 2 13:28

$HCA Healthcare (HCA.US)$ It’s buyable in the long term as an investment. Short term might need some time to bottom and there might be some earning deceleration/normalization risk. The chart would touch the up trend started from the pendamic low for the fourth time, which typically means the trend is old.

韭菜变主力

Jan 2 13:12

$HCA Healthcare (HCA.US)$ From 2019 to 2024, the revenue increased by 38%, EPS increased by 108%, that’s a revenue CGAR of 6.6% and EPS CGAR of 15.8%. The EBITDA margin is about the same at 18% in 2019 and 2024. The magic of this outsized EPS growth is share repurchase at a relatively low TTM P/E=13-14. The share price from this period precisely reflected that amazing EPS growth and the P/E didn’t expand. It’s a pretty good investment if the revenue CGAR of 6-7% can be achieved consistently (2-3%...

HCA HCA Healthcare

Trade Overview

Capital Trend

News

Comments

Market Insights

Latest News

Investment Course

Discussing

Earnings Season Underway